+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone



Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone



European Journal of Surgical Oncology 25(6): 610-618



Intralesional treatment of giant cell tumour (GCT) of the bone may result in a high rate of local recurrence. The introduction of local adjuvant therapy, such as cementation or phenolization, has lead to a significant reduction in recurrence rates. Due to the combined use of phenol and cementation in most studies, the effect of phenol alone is described in this study. Twenty primary and nine recurrent surgical procedures in 26 patients with GCT of the bone with a median follow-up of 61 months were reviewed retrospectively. The mean age was 33.5 years (range 13.5-76.5 years). Eighteen curettages and 11 resections were performed. For the curettages, a large bone window was cut followed by high speed burring and bone graft reconstruction. In 11 of 18 curettages and three of 12 resections, phenol was additionally applied. Four patients showed pulmonary metastasis. Three of these four cases also experienced local recurrences. Three patients died due to metastatic disease. In total, five patients developed local recurrence (17.2%); three in the first 2 years and one after 4 years. Four of 18 curettages recurred (22.2%), compared to one of 11 resections (9.1%). Only one of 11 patients (9.1%) treated with curettage and adjuvant phenol recurred, whereas three of seven patients (42.9%) treated with curettage alone recurred. Phenolization is an effective and safe local adjuvant therapy for GCT. We did not observe any significant differences in recurrence rates for curettage, phenolization and bone grafting compared to most published results using cryosurgery or cementation alone. We recommend adjuvant phenolization in the treatment of GCT of the bone after careful curettage in applicable cases, regardless of whether additional cementation is used.

(PDF emailed within 0-6 h: $19.90)

Accession: 046973212

Download citation: RISBibTeXText

PMID: 10556009

DOI: 10.1053/ejso.1999.0716


Related references

Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. International Orthopaedics 30(6): 495-498, 2006

Local recurrence of giant cell tumour of bone after intralesional treatment with and without adjuvant therapy, a single institution case series. Jpma. Journal of the Pakistan Medical Association 65(11 Suppl 3): S105-S114, 2016

Similar local control between phenol- and ethanol-treated giant cell tumors of bone. Clinical Orthopaedics and Related Research 469(11): 3200-3208, 2011

Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant. International Orthopaedics 30(6): 490-494, 2006

Late recurrence of giant cell tumour of bone after curettage and adjuvant treatment: a case report. Journal of Orthopaedic Surgery 18(1): 122-125, 2010

Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. Journal of Bone and Joint Surgery. American Volume 90(5): 1060-1067, 2008

Adjuvant therapy (phenol, bone cement) in giant cell tumors. Zeitschrift für Orthopadie und ihre Grenzgebiete 130(2): 95-98, 1992

Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. European Journal of Surgical Oncology 27(2): 200-202, 2001

Phenol as an adjuvant in the control of local recurrence of benign neoplasms of bone treated by curettage. Italian Journal of Orthopaedics and Traumatology 11(3): 381-388, 1985

A prospective study on predicting local recurrence of giant cell tumour of bone by evaluating preoperative imaging features of the tumour around the knee joint. La Radiologia Medica 122(7): 546-555, 2017

Wide resection versus curettage with adjuvant therapy for giant cell tumour of bone. Journal of Orthopaedic Surgery 25(2): 2309499017718932, 2017

Wide resection versus curettage with adjuvant therapy for giant cell tumour of bone. Journal of Orthopaedic Surgery 24(2): 228-231, 2017

Bisphosphonate-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Tumor of Bone: A 1 to 12-Year Follow-up Study. American Journal of Clinical Oncology 42(3): 231-237, 2019

Ethanol as a local adjuvant for giant cell tumor of bone. Iowa Orthopaedic Journal 26: 69-76, 2006

Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone. Journal of Orthopaedic Surgery 24(1): 88-91, 2017